FOXO TECHNOLOGIES INC. Conversion of Stock, Shares Converted
FOXO TECHNOLOGIES INC. (FOXO) reported Conversion of Stock, Shares Converted of 871.26 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2024-06-06
- FOXO TECHNOLOGIES INC. conversion of stock, shares converted for fiscal 2022 was 871.26K shares.
| Period end | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 6 month as first filed | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|
| 2022-12-31 | 871.26K shares 10-K · filed 2023-03-31 | ||
| 2022-06-30 | 87.13K shares 10-K · filed 2024-06-06 | 871.26K shares 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |